Radiotherapy of a CXCR4-Expressing Lymphoma Mouse Model with [177Lu]Lu-BL01

Conclusion: [177Lu]Lu-BL01, a new CXCR4 targeting peptide, demonstrates radiotherapeutic efficacy in a mouse model of non-Hodgkin B-cell lymphoma.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Kwon, D., Rousseau, E., Lau, J., Zhang, Z., Merkens, H., Gitschtaler, K., Zhang, C., Lin, K.-S., Benard, F. Tags: Preclinical Probes for Oncology Posters Source Type: research